HIND
Vyome Holdings, Inc
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Operating Income
$-10452570
↓ 35.3%
Gross Profit
$218771
↓ 95.7%
Revenue
$319714
↑ 24.4%
Net Income
$-10262007
↓ 43.9%
EPS (Diluted)
$-4.86
↑ 64.9%
Total Liabilities
$2.7M
↓ 45.8%
Total Assets
$6.5M
↑ 35.6%
Cash & Equivalents
$5.0M
↑ 619.0%

Recent SEC Filings

Form Type Filed Date Link
4 9/3/2026 View on SEC
3 9/1/2026 View on SEC
8-K 8/28/2026 View on SEC
8-K 8/25/2026 View on SEC
10-Q 8/12/2026 View on SEC
8-K 5/29/2026 View on SEC
10-Q 5/12/2026 View on SEC
8-K 4/29/2026 View on SEC
DEF 14A 3/31/2026 View on SEC
PRE 14A 3/20/2026 View on SEC

Company Information

Field Value
Ticker HIND
Company Name Vyome Holdings, Inc
CIK 1427570
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 949-429-6680